- Home
- CELH vs ELAN Comparison
CELH vs ELAN Comparison
Compare CELH & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELH
- ELAN
- Stock Information
- Founded
- CELH 2004
- ELAN 1954
- Country
- CELH United States
- ELAN United States
- Employees
- CELH N/A
- ELAN N/A
- Industry
- CELH Beverages (Production/Distribution)
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- CELH Consumer Staples
- ELAN Health Care
- Exchange
- CELH Nasdaq
- ELAN Nasdaq
- Market Cap
- CELH 6.8B
- ELAN 6.3B
- IPO Year
- CELH N/A
- ELAN 2018
- Fundamental
- Price
- CELH $29.31
- ELAN $13.35
- Analyst Decision
- CELH Strong Buy
- ELAN Buy
- Analyst Count
- CELH 16
- ELAN 6
- Target Price
- CELH $55.63
- ELAN $17.00
- AVG Volume (30 Days)
- CELH 8.3M
- ELAN 4.6M
- Earning Date
- CELH 11-06-2024
- ELAN 11-07-2024
- Dividend Yield
- CELH N/A
- ELAN N/A
- EPS Growth
- CELH 47.74
- ELAN N/A
- EPS
- CELH 0.72
- ELAN 0.41
- Revenue
- CELH $1,370,868,000.00
- ELAN $4,454,000,000.00
- Revenue This Year
- CELH $8.27
- ELAN $2.22
- Revenue Next Year
- CELH $18.50
- ELAN $2.77
- P/E Ratio
- CELH $40.76
- ELAN $32.38
- Revenue Growth
- CELH 19.36
- ELAN 1.99
- 52 Week Low
- CELH $25.23
- ELAN $11.40
- 52 Week High
- CELH $99.62
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- CELH 49.45
- ELAN 46.92
- Support Level
- CELH $25.23
- ELAN $13.15
- Resistance Level
- CELH $28.31
- ELAN $13.58
- Average True Range (ATR)
- CELH 1.52
- ELAN 0.51
- MACD
- CELH 0.19
- ELAN 0.00
- Stochastic Oscillator
- CELH 59.48
- ELAN 41.67
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages (including those that are naturally caffeinated with stevia), Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.